Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2005
05/19/2005CA2544752A1 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
05/19/2005CA2544213A1 Imidazo[1,2-a]pyridine anxiolytics
05/19/2005CA2543707A1 Nitrogen-containing fused heterocyclic compounds
05/18/2005EP1530465A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound
05/18/2005EP1263724B1 Novel compounds
05/18/2005CN1617869A 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617666A Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same
05/18/2005CN1615873A Azaindoles compound
05/18/2005CN1202108C Spiro compounds, preparing method and intermediate
05/18/2005CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
05/17/2005US6894165 Imidazonaphthyridines
05/17/2005US6894057 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
05/17/2005US6894042 Azabicyclic compounds for the treatment of disease
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893614 Reaction device for organic synthesis
05/12/2005WO2005042697A2 Compounds, compositions and methods
05/12/2005WO2005042537A1 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042532A1 Bispidon-derivated ligands and complex for catalytically bleaching a substrate
05/12/2005WO2005042531A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates
05/12/2005WO2005042530A1 Rsv polymerase inhibitors
05/12/2005WO2005042501A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005WO2005042498A2 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005041971A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005WO2005041664A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005021519A3 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
05/12/2005WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
05/12/2005WO2004096802A3 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES
05/12/2005WO2004073628A3 Novel compounds
05/12/2005WO2004064778A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/12/2005WO2004009590A8 4-amino-substituted pyrimidine derivatives
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101647 For example, 2-(1,3-benzodioxol-5-yl)-6-phenyl-1H-imidazo[4,5-b]pyridinetyrosine; kinase-inhibiting activity; use in treatment of breast cancer, prostate cancer, lung cancer or pancreatic carcinoma
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101628 Useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies
05/12/2005US20050101627 Preparation of 1H-imidazo [4,5-C] quinolin-4 amines via novel 1h-imidazo [4,5-C] quinolin-4-cyano and 1h-imidazo [4,5-C] quinolin-4-carboxamide intermediates
05/12/2005US20050101626 Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
05/12/2005US20050101623 Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
05/12/2005US20050101615 Pyridopyrimidine or naphthyridine derivative
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101603 Compound and method for the treatment of pain
05/12/2005US20050101595 N-containing cycloalkyl-substituted amino-thiazole derivatives and pharmaceutical compositions for inhibiting cell proliferation and methods for their use
05/12/2005US20050101593 Phosphoric acid salt of an integrin receptor antagonist
05/12/2005US20050101592 3-(4-chlorophenyl)-2-(2-chlorophenyl)-7-(2,2,2-trifluoroethyl)-6,7-dihydro-2H,5H-4-oxa-1,2,7-triaza-azulen-8-one; for treatment of disorders linked to mediation of cannabinoid receptors
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/12/2005US20050101569 Methods and compositions for selectin inhibition
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005CA2543533A1 2-cyanopyrrolidinecarboxamide compound
05/12/2005CA2542536A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005CA2542047A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
05/12/2005CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
05/11/2005EP1529781A1 A process for the preparation of Imiquimod and intermediates thereof
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
05/11/2005EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
05/11/2005CN1615309A Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
05/11/2005CN1615300A Benzimidazole derivatives and their use as GNRH antagonists
05/11/2005CN1615299A Xanthine oxidase inhibitors
05/11/2005CN1200938C Process for preparing 8-methoxy-quinolone
05/11/2005CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/10/2005US6891039 2-(4-Fluorophenyl)-1-(2-cyclopentylamino-4-pyrimidinyl)-5-(piperidino-N -2-ethyl)imidazo(4,5-b)pyridine, for example; MAP kinase inhibitors, for Tumor Necrosis Factor (TNF-alpha) and Interleukin-1 (IL-1) disorders such as osteoporosis
05/10/2005US6890945 Administering a imidazo(4,5,1-ij)quinoline compound
05/10/2005US6890934 Hypoglycemic agents; muscle relaxants; bronchodilator agents; antiallergens
05/10/2005US6890933 Kinesin inhibitors
05/10/2005US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
05/06/2005WO2005040355A2 Tao kinase modulators and methods of use
05/06/2005WO2005040174A1 Tetrahydro-furo`3,4-d!dioxole compounds and compositions and method for inhibiting platelet aggregation
05/06/2005WO2005040169A2 Fused heterocyclic compounds as serotonin receptor modulators
05/06/2005WO2005040168A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors
05/06/2005WO2005040167A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
05/06/2005WO2005040166A1 Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
05/06/2005WO2005040165A1 Diazabicyclononene derivatives and their use as renin inhibitors
05/06/2005WO2005040164A1 Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
05/06/2005WO2005040159A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
05/06/2005WO2005040155A1 Pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists
05/06/2005WO2005040111A2 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids
05/06/2005WO2005040073A2 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids
05/06/2005WO2005039589A2 Cftr channel modulators
05/06/2005WO2005039575A1 Remedy for hyperlipemia
05/06/2005WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors
05/06/2005WO2005039486A2 Compounds and compositions as protein kinase inhibitors
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005WO2004089304A3 Antiandrogens with marginal agonist activity and methods of use
05/06/2005WO2004080402A3 Potassium salt of an hiv integrase inhibitor
05/06/2005CA2782783A1 Fused heterocyclic compounds
05/06/2005CA2542720A1 Azabenzodiazepines as phosphodiesterase-4 inhibitors
05/06/2005CA2542522A1 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
05/06/2005CA2542226A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
05/06/2005CA2542064A1 Tao kinase modulators and methods of use
05/06/2005CA2540782A1 Diazabicyclononene derivatives and their use as renin inhibitors
05/06/2005CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists
05/06/2005CA2536535A1 Compounds and compositions as protein kinase inhibitors
1 ... 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 ... 646